PAVMED INC (PAVM)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$5.28+3.73%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · PAVM
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 0.1 | 0.1 | 3.0 | 2.5 | 0.4 | 0.5 | — | — | — | — | — |
| Total Revenues | — | — | 3.0 | 2.5 | — | — | — | — | — | — | — |
| Cost of Revenues | 0.4 | 0.2 | 4.8 | 6.4 | 3.6 | 0.6 | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | (0.1) | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||
| R&D Expenses | 6.4 | 4.5 | 5.9 | 14.3 | 25.3 | 19.8 | 11.0 | 6.6 | 4.3 | 2.6 | 1.7 |
| Operating Income | (26.7) | (21.8) | (44.5) | (68.8) | (91.1) | (54.4) | (23.4) | (14.3) | (10.6) | (8.0) | — |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | 0.0 | — | — | — | — | — | — | 2.4 | 0.7 | — |
| Interest & Investment Income | — | 0.0 | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 10.3 | 19.3 | 72.9 | (10.5) | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (16.4) | (2.5) | 28.4 | (79.3) | (103.2) | (56.1) | (35.9) | (17.3) | (18.2) | (9.5) | — |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | (18.2) | — | — |
| Net Income | |||||||||||
| Minority Interest | (4.3) | (2.9) | (11.4) | (15.1) | (14.3) | (5.8) | (1.6) | (0.8) | (0.2) | — | — |
| Net Income | (16.3) | 0.4 | 39.8 | (66.3) | (89.0) | (50.3) | (34.3) | (16.5) | (18.0) | (9.5) | (5.7) |
| Per Share | |||||||||||
| Basic EPS | (2.59) | (5.63) | 3.30 | (9.16) | (15.03) | (0.65) | — | — | — | — | — |
| Diluted EPS | (2.59) | (5.63) | 0.50 | (9.16) | (15.03) | — | — | — | — | — | — |
| Revenue per Share | 0.02 | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 6.3 | 0.7 | 9.7 | 7.2 | 5.9 | 77.5 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 6.3 | 0.7 | 65.3 | 7.2 | 5.9 | — | — | — | — | — | 13.0 |
| Supplemental | |||||||||||
| EBITDA | — | (21.7) | (43.3) | (65.9) | (88.6) | (54.2) | — | — | — | — | — |
| EBIT | (26.7) | (21.8) | (44.5) | (68.8) | (91.1) | (54.4) | (23.4) | (14.3) | (10.6) | (8.0) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.